Роль дефектов иммуносупрессии в развитии аутоиммунных заболеваний

1. <div><p>Davidson A., Diamond В. Autoimmune disease. New Engl. Med., 2001,345, 340-350</p><p>Zhou J., Carr R.I., Liwski R.S. et al. Oral exposure lo alloanti- gen generates intragraft CD8+ regulatory cells. J. Immunol., 2001,167, 107-113</p><p>Gilliet М., Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp Med., 2002, 195, 695-704</p><p>Ciubotariu R., Colovai A.I., Pennesi G. et al. Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28- regulatory T cells. J. Immunol., 1998, 161, 51932024</p><p>Zhang Z.X., Yang L., Young K.J. et al. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat. Med., 2000, 6, 782-789</p><p>Seino K., Taniguchi M. Functional roles of NKT cell in the immune system. Front. Biosci., 2005, 10, 38-48</p><p>Groux Н., O'Garra A., Bigler М. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature, 1997, 389, 737-742</p><p>Roncarolo M.G., Bacchetta R., Bordignon C. et al. Type I T regulatory cells. Immunol. Rev., 2001, 182, 68-79</p><p>Sundstedt A., O'Neill E.J., Nicolson K.S., Wraith D.C. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol., 2003, 170, 1240-1248</p><p>Wakkach A., Fournier N., Brun V. et al. Characterization of dendritic cells that induce tolerance and T regulatory I cell differentiation in vivo. Immunity, 2003, 18, 605-617</p><p>Buckner J.H., Ziegler S.F. Regulating the immune system: the induction of regulatory T cells in the periphery. Arthr.Res.Ther., 2004. 6,215-222</p><p>Hall B.M., Pearce N.W., Gurley K.E., Dorsch S.E. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J. Exp. Med., 1990, 171. 141-157</p><p>Sakaguchi S., Sakaguchi N., Asano M. et al. Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 1995, 155(3), 1151-1164</p><p>Baechcr-Allan C., Brown J.A., Freeman G.J., Haller D.A. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol., 2001, 167, 1245-1253</p><p>Annunziato F., Cosmi L., Liotta F. et al. Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes J. Exp. Med., 2002, 196, 379-387</p><p>Jonuleit H., Schmitt E., Stassen M. et al. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med., 2001, 193, 1285-1294</p><p>Dieckmann D., Plottner H., Berchtold S. et al. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med., 2001, 193, 1303-1310</p><p>Takahashi Т., Kuniyasu Y., Toda M. et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol., 1998, 10, 19691980</p><p>Salomon B., Lenschow D.J., Rhee L. et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity., 2000, 12, 431-440</p><p>Shevach E.M., McHugh R.S., Thornton A.M. et al. Control of autoimmunity by regulatory T cells. Adv. Exp. Med. Biol., 2001, 490. 21-32</p><p>Нага М., Kingsley C.I., Niimi M. et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigcns in vivo. J. Immunol., 2001, 166, 3789-3796</p><p>Taylor RA., Noelle P.J., Blazar B.R. CD4+CD25+ immune regulatory cellsare required for induction oftolersnce to alloantigen via costimulatory blockade. J. Exp. Med., 2001, 193, 1311-1318</p><p>Aluvihare V.R., Kallikourdis М., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol., 2004, 5, 266-271</p><p>Piccirillo C.A., Shevach E.M. Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol., 2004,16, 81-88</p><p>Kullberg M.C. Jankovic D., Gorelick P.L. et al. Bacteria-trig- gered CD4(+) T regulatory cells suppress Helicobacter hepati- cus-induced colitis. J. Exp. Med., 2002, 196, 505-515</p><p>Maloy K.J., Salaun L., Cahill R. et al. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanismsJ. Exp. Med., 2003, 197, 111-119</p><p>Hori S., Carvalho T.L., Demengeot J. CD25+CD4+ regulatory T cells suppress СD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol., 2002, 32, 1282-1291</p><p>Hesse М., Piccirillo C.A., Belkaid Y. et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol., 2004. 172, 3157-3166</p><p>BonomoA,, Kehn P.J., Shevach E.M. Post-thymectomy autoimmunity: abnormal T-cell homeostasis. Immunol. Today, 1995, 16,61-67</p><p>Asano М., Toda М., Sakaguchi N. Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med., 1996, 184, 387-396</p><p>Seddon B., Mason D. The third function of the thymus. Immunol. Today, 2000, 21, 95-99</p><p>Sanchez J., Casano J., Alvarez M.A. et al. Kinetic of regulatory CD25high and activated CD 134+ (0X40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br. J. Haematol., 2004, 126, 697-703</p><p>Tone М., Tone Y., Adams E. et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory forT cells. Proc. Natl. Acad. Sci. USA, 2003, 100, 15059-15064</p><p>Uraushihara K., Kanai Т., Ко К. et al. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells. J. Immunol., 2003, 171,708-716</p><p>You S., Slehoffer G., Barriot S. et al. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA, 2004, 101. suppl. 2, 14580-14585</p><p>Thompson C.B., Allison J.P. The emerging role of CTLA-4 as an immune attenuator. Immunity, 1997,7, 4, 445-550</p><p>Maloy K.J., Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol., 2001, 2, 816-22</p><p>Sakaguchi S., Sakaguchi N., Shimizu J. et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev., 2001, 182, 18-32</p><p>Nakamura K., Kitani A., Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med., 2001, 194, 5, 629-644</p><p>Fu S., Yopp A.C., Мао X. et al. CD4+ CD25+ CD62+ T-regu- latory cell subset has optimal suppressive and proliferative potential. Am. J. Transplant., 2004, 4, 65-78</p><p>Fisson S., Darrassc-JezeG., Litvinova E.et al. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J. Exp. Med., 2003, 198, 737-746</p><p>Walker L.S., Chodos A., Eggena M. et al. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med., 2003, 198,249-258</p><p>Thornton A.M., Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med., 1998, 188, 287-296</p><p>Dieckmann D., Bruett C.H., Ploettner H. et al. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type t-likc regulatory T cells. J. Exp. Med., 2002, 196, 247-253</p><p>Jonuleit H., Schmitt E., Kakirman H. et al. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med., 2002, 196. 255-260</p><p>Annunziato F., Cosmi L„ Liotta F. et al. Phenotype, localization, and mechanism of suppression ofCD4(+)CD25(+) human thymocytes. J. Exp. Med., 2002, 196, 379-387</p><p>Levings M.K., Bacchetta R., Schulz U., Roncarolo M.G. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells.Int. Arch. Allergy Immunol., 2002, 129,263-276</p><p>Nakamura K., Kitani A., Fuss I. et al. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J. Immunol., 2004, 172, 834-842</p><p>Roncarolo M.G., Gregori S., Levings M. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells. Novartis Found Symp., 2003, 252, 115-127</p><p>Kingsley C.I., Karim М., Bushell A.R., Waod K.J. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA- 4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol., 2002, 168, 1080-1086</p><p>Asseman C., Mauze S., Leach M.W. et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med., 1999, 190, 995-1004</p><p>Belkaid Y., Piccirillo CA., Mendez S. et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature, 2002, 420, 502-507</p><p>Waterhouse P., Penninger J.M., Timms E. et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Sciencc, 1995, 270, 985-988</p><p>Tivol E.A., Borriello F„ Schweitzer A.N. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity, 1995, 7, 541-547</p><p>Karandikar N.J., bnderlugt C.L., WklunasT.L. et al. CTLA-4: a negative regulator of autoimmune disease. J Exp Med., 1996, 184, 783-788</p><p>Perrin P.J., Maldonado J.H., Davis T.A. et al. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol., 1996, 157, 1333-1336</p><p>Luhder F., Hoglund P., Allison J.P. et al. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med., 1998,187,427-432</p><p>Takahashi Т., Tagami Т., Yamazaki S. et al. Immunologic selftolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med., 2000, 192, 303-310</p><p>Hori S., Nomura Т., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299, 1057-10</p><p>Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol., 2003, 4, 330-336</p><p>Wfclker M.R., Kasprowicz D.J., Gersuk V.H. et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest., 2003, 112, 14371443</p><p>Ramsdell F. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity, 2003, 19, 165-168</p><p>Wildin R.S., Smyk-Pearson S., Filipovich A.H. Clinical and molecular features of the immunodysregulation, polyen- docrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet., 2002, 39, 537-545</p><p>Bennett C.L., Christie J., Ramsdell F. et al. The immune dys- regulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet., 2001, 27, 20-21</p><p>Chen W., Jin W., Hardegen N. et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med., 2003, 198, 1875-1886</p><p>Fu S., Zhang N., Yopp A.C. et al. TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors. Am. J. Transplant., 2004, 4, 1614-1627</p><p>Fantini M.C., Becker C., Monteleone G. et al. TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol., 2004, 172,5149-5153</p><p>Papiemik M.t de Moraes M.L., Pontoux C. et al. C. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol., 1998, 10, 371-378</p><p>MalekT.R., Furse R.K., Fleming M.L. et al. Biochemical identity and characterization of the mouse interleukin-2 receptor beta and gamma с subunits J Interferon Cytokine Res., 1995, 15,447578</p><p>Sadlack B., Merz H., Schorle H. et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell, 1993, 75, 253-261</p><p>Sadlack B., LohlerJ., Schorle H. et al. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur. J. Immunol., 1995, 25, 3053-3059</p><p>Thornton A.M., Donovan E.E., Piccirillo C.A., Shevach E.M. Cutting edge: I L-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor func. J. Immunol., 2004, 172, 6519-6523</p><p>Via C.S., Handwerger B.S. В-cell and T-cell function in systemic lupus erythematosus. Curr. Opin. Rheumatol., 1993, 5, 570-574</p><p>Dean G.S., Tyrrell-Price J., Crawley E., Isenberg D.A. Cytokines and systemic lupus erythematosus. Ann. Rheum. Dis., 2000,59, 243-251</p><p>Liu M.F., Wing C.R., Fung L.L., Wu C.R. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand. J. Immunol., 2004, 59, 198202</p><p>Crispin J.C., Martinez A., Alcocer-Vhrela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun., 2003, 21, 273-276</p><p>Ohtsuka K., GrayJ.D., Stimmler M.M. et al. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus. J. Immunol., 1998, 160, 25392545</p><p>Zheng S.G., VVkngJ.H., Koss M.N. et al. CD4+and CD8+regulatory T cells generated ex vivo with I L-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol., 2004, 172, 1531-1539</p><p>Morgan M.E., Sutmuller R.P., Witteveen H.J. et al. CD25+cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis. Rheum., 2003, 48, 1452-1460</p><p>Ehrenstein M.R., Evans J.G., Singh A. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med., 2004, 200, 277-285</p><p>Prakken B.J., Samodal R., Le T.D. et al. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA, 2004,101,4228-4233</p></div><br />